Printed on 7/20/2026
For informational purposes only. This is not medical advice.
The UCLA 3-item loneliness scale is a concise social-connection screening tool used to identify perceived loneliness and social isolation risk in healthcare and community settings.
Formula: Total loneliness score = sum of 3 items (range 3-9).
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
The patient rates 3 items on a 1-3 scale: 1 = Hardly ever, 2 = Some of the time, 3 = Often. Items assess: (1) How often do you feel you lack companionship? (2) How often do you feel left out? (3) How often do you feel isolated from others?
Sum all 3 items for a total score of 3-9 (minimum 1 per item, maximum 3 per item). No reverse scoring required. Higher scores indicate greater loneliness. A score of 3 indicates no loneliness; a score of 9 indicates maximum loneliness on all three dimensions.
Score interpretation: 3-4 = not lonely or mild loneliness; 5-6 = moderate loneliness — warrants clinical inquiry and potential social prescription; 7-9 = severe loneliness — associated with significant health risks including 26% increased mortality risk. High scores warrant assessment for depression, social isolation, and referral to community support.
General Practitioners
Loneliness is a significant risk factor for cardiovascular disease, dementia, and premature mortality — comparable to smoking 15 cigarettes per day (Holt-Lunstad 2015). The UCLA-3 enables rapid social isolation screening in primary care, identifying patients who would benefit from social prescribing referrals, community engagement programs, or mental health support.
Geriatricians and Aged Care Teams
Loneliness affects 20-43% of older adults and is the strongest modifiable risk factor for dementia after age 65 (Holwerda et al. 2014, OR 1.64). Routine UCLA-3 screening in geriatric care identifies lonely older adults who need social prescribing, befriending services, day programs, or family connection interventions before dementia and depression develop.
Public Health Professionals
The COVID-19 pandemic increased loneliness prevalence dramatically across all age groups, with the largest increases in young adults aged 18-25. UCLA-3 provides a validated, brief tool for ongoing post-pandemic loneliness surveillance and monitoring the effectiveness of community reconnection programs in healthcare and public health settings.
Palliative and Hospice Care Teams
Social connection is a core domain of palliative care quality of life alongside physical symptom management, psychological wellbeing, and spiritual care. UCLA-3 enables systematic assessment of loneliness in patients with serious illness, identifying those needing chaplaincy services, volunteer companionship programs, and family engagement support.
Psychiatrists and Mental Health Professionals
Loneliness is a strong risk factor for depression, anxiety, and psychosis, and is highly comorbid with these conditions. UCLA-3 screening in mental health settings identifies loneliness as a contributing factor to poor mental health outcomes, enabling targeted social interventions alongside pharmacotherapy and psychotherapy.
Population Health and Care Coordination Teams
Loneliness is a core social determinant of health affecting outcomes across multiple chronic disease categories. Including UCLA-3 in comprehensive social needs screening (alongside housing, food security, and transportation) enables care coordination teams to identify and address loneliness as a modifiable social risk factor in population health management programs.
Loneliness is the subjective perception of inadequate social connection. It is distinct from objective social isolation (being physically alone). People with large social networks can be severely lonely; people who live alone may not be lonely at all. UCLA-3 measures perceived loneliness, which is the construct most strongly associated with adverse health outcomes.
Holt-Lunstad et al. (2015) meta-analysis (148 studies, 308,849 participants): loneliness and social isolation are associated with a 26-29% increased risk of premature mortality — comparable to smoking 15 cigarettes per day and more harmful than obesity. This effect is independent of age, gender, and health status, establishing loneliness as a major public health concern.
Holwerda et al. (J Neurol Neurosurg Psychiatry 2014) found that feelings of loneliness (not objective isolation) predict dementia with an odds ratio of 1.64 after controlling for other risk factors. The mechanism may involve reduced cognitive stimulation, increased stress-related neuroinflammation, and decreased sleep quality associated with loneliness.
Hughes et al. (Res Aging 2004) validated the 3-item UCLA scale in the Health and Retirement Study (N=2,167 adults aged 50+). Internal consistency alpha 0.72. Concurrent validity confirmed against social support measures and comparison with the full 20-item UCLA Loneliness Scale (correlation 0.82). The 3-item version captures the full loneliness construct with sufficient precision for clinical screening.
Evidence-based loneliness interventions: (1) Social prescribing — referral to community groups, volunteer programs, walking groups; (2) Befriending services — volunteer companionship programs; (3) Digital social connection — video calling programs for elderly; (4) CBT for loneliness — addresses maladaptive social cognitions; (5) Group-based programs targeting specific populations (cancer survivors, new parents, veterans).
Loneliness affects 20-43% of adults aged 65+. Risk factors include: bereavement (especially loss of spouse), retirement, mobility limitations, sensory impairment (hearing loss is particularly strong loneliness predictor), cognitive decline, and reduced driving ability limiting community access. Routine UCLA-3 screening should be part of every geriatric assessment.
Killgore et al. (Psychiatry Res 2020) and subsequent studies showed COVID-19 pandemic-related isolation increased loneliness prevalence across all age groups by 20-40%. Young adults (18-25) showed the largest increases. Post-pandemic community reconnection is incomplete for many individuals, making ongoing loneliness screening important even years after restrictions ended.
Loneliness and depression are highly comorbid (correlation r approximately 0.55) but are distinct constructs requiring different treatment approaches. Depression requires clinical treatment (psychotherapy and/or antidepressants). Loneliness requires social interventions (social prescribing, CBT for social cognition, befriending). Treating only one without addressing the other produces incomplete recovery.
Research shows that patients rarely spontaneously disclose loneliness due to stigma and shame. However, when directly asked in a normalized, non-judgmental way ('Many people feel lonely at times — is this something you're experiencing?'), patients are willing to discuss it. Direct inquiry is the most effective clinical tool for identifying loneliness, and UCLA-3 provides structure to this conversation.
UCLA Loneliness Scale (20-item) published by Russell, Peplau and Cutrona (J Pers Soc Psychol 1980). 3-item version validated by Hughes et al. (Res Aging 2004) from Health and Retirement Study (N=2167). 3-item alpha 0.72; construct validity against social support measures confirmed. Loneliness and mortality meta-analysis: Holt-Lunstad et al. (Perspect Psychol Sci 2015) — OR 1.26 for premature mortality. Loneliness and dementia: Holwerda et al. (J Neurol Neurosurg Psychiatry 2014). COVID-19 loneliness: Killgore et al. (Psychiatry Res 2020).
Higher scores indicate greater perceived loneliness and support targeted social-connection interventions.
Use in primary care, geriatrics, and community-health screening where social isolation risk may affect health outcomes.
The scale is brief and perception-based; it does not by itself measure objective social network size or diagnose psychiatric disorders.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Free PHQ-9 depression screening questionnaire. Take the Patient Health Questionnaire-9 to assess depression severity with instant scoring and interpretation. Also screen for anxiety with [GAD-7](/tools/gad7).
OpenMental HealthMeasure recent positive well-being with the 5-item WHO-5 index and percentage score.
OpenMental HealthScreen anxiety and depression symptom burden using the 14-item HADS (HADS-A + HADS-D).
Open